Psychiatry Research: Neuroimaging
Volume 183, Issue 1 , Pages 44-51 , 30 July 2010

The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia

  • Christian Luckhaus

      Affiliations

    • Department of Psychiatry and Psychotherapy, Heinrich-Heine-University, Duesseldorf, Germany
    • Corresponding Author InformationCorresponding author. Department of Psychiatry and Psychotherapy, Heinrich-Heine-University, Bergische Landstrasse 2, 40629 Düsseldorf, Germany. Tel.: +49 211 9222741; fax: +49 211 9222745.
    • ,
  • Mathias Cohnen

      Affiliations

    • Department of Radiology, Städtische Kliniken Neuss, Lukaskrankenhaus GmbH, Neuss, Germany
    • ,
  • Michael Oliver Flüβ

      Affiliations

    • Department of Radiology and Nuclear Medicine, Private Practice Association, Neuss, Germany
    • ,
  • Michaela Jänner

      Affiliations

    • Department of Psychiatry and Psychotherapy, Heinrich-Heine-University, Duesseldorf, Germany
    • ,
  • Brigitte Grass-Kapanke

      Affiliations

    • Department of Geriatric Psychiatry, Alexian Hospital, Krefeld, Germany
    • ,
  • Stefan J. Teipel

      Affiliations

    • Department of Psychiatry and Psychotherapy, University of Rostock, Germany
    • German Center for Neurodegenerative Disease (DZNE), Bonn, Germany
    • ,
  • Michel Grothe

      Affiliations

    • Department of Psychiatry and Psychotherapy, University of Rostock, Germany
    • Laboratory of Functional Neuroscience, University Pablo de Olavide, Seville, Spain
    • ,
  • Harald Hampel

      Affiliations

    • Department of Psychiatry, Dementia and Neuroimaging Research Section, Alzheimer Memorial Center and Psychiatric Research Branch, Ludwig-Maximilian University, Munich, Germany
    • Discipline of Psychiatry, School of Medicine & Trinity College Institute of Neuroscience (TCIN), Laboratory of Neuroimaging and Biomarker Research, Trinity College Dublin, The Adelaide and Meath Hospital incorporating the National Children's Hospital (AMiNCH), Dublin, Ireland
    • ,
  • Oliver Peters

      Affiliations

    • Department of Psychiatry and Psychotherapy, Charité, University of Berlin, Germany
    • ,
  • Johannes Kornhuber

      Affiliations

    • Department of Psychiatry and Psychotherapy, University of Erlangen, Germany
    • ,
  • Wolfgang Maier

      Affiliations

    • Department of Psychiatry and Psychotherapy, University of Bonn, Germany
    • ,
  • Tillmann Supprian

      Affiliations

    • Department of Psychiatry and Psychotherapy, Heinrich-Heine-University, Duesseldorf, Germany
    • ,
  • Wolfgang Gaebel

      Affiliations

    • Department of Psychiatry and Psychotherapy, Heinrich-Heine-University, Duesseldorf, Germany
    • ,
  • Ulrich Mödder

      Affiliations

    • Department of Radiology and Nuclear Medicine, Private Practice Association, Neuss, Germany
    • ,
  • Hans-Jörg Wittsack

      Affiliations

    • Department of Radiology and Nuclear Medicine, Private Practice Association, Neuss, Germany

Received 20 October 2008 ,Revised 11 February 2010 ,Accepted 8 April 2010.

References 

  1. Basso M, Yang J, Warren L, MacAvoy MG, Varma P, Bronen RA, et al. Volumetry of amygdala and hippocampus and memory performance in Alzheimer's disease. Psychiatry Research: Neuroimaging. 2006;146:251–261
  2. Chételat G, Desgranges B, Landeau B, Mézenge F, Poline JB, de la Sayette V, et al. Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease. Brain. 2008;131:60–71
  3. Colliot O, Chételat G, Chupin M, Desgranges B, Magnin B, Benali H, et al. Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus. Neuroradiology. 2008;248:194–201
  4. Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, et al. Hippocampal and entorhinal atrophy in mild cognitive impairment. Prediction of Alzheimer disease. Neurology. 2007;68:828–836
  5. Duarte A, Hayaska S, Du A, Schuff N, Jahng G-H, Kramer J, et al. Volumetric correlates of memory and executive function in normal elderly, mild cognitive impairment and Alzheimer's disease. Neuroscience Letters. 2006;406:60–65
  6. Fakhri GE, Kijewski MF, Johnson KA, Syrkin G, Killiany RJ, Becker JA, et al. MRI-guided SPECT perfusion measures and volumetric MRI in prodromal Alzheimer disease. Archives of Neurology. 2003;60:1066–1072
  7. Folstein MF, Folstein SE, McHugh PR. Mini Mental State: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research. 1975;12:189–198
  8. Förstl H, Czech C, Sattel H, Geiger-Kabisch C, Besthorn C, Kreger S, et al. Apolipoprotein E und Alzheimer Demenz. Nervenarzt. 1994;65:780–786
  9. Gould RL, Brown RG, Owen AM, Bullmore ET, Williams SCR, Howard RJ. Functional neuroanatomy of successful paired associate learning in Alzheimer's disease. American Journal of Psychiatry. 2005;162:2049–2060
  10. Hampel H, Bürger K, Teipel SJ, Bokde ALW, Zetterberg H, Blennow K. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease. Alzheimer's & Dementia. 2008;4:38–48
  11. WMS-R Wechsler Gedächtnistest – revidierte Fassung. In:  Härting C,  Markowitsch HJ,  Neufeld H editor. Deutsche Adaption der Wechsler Memory Scale. Bern, Göttingen: Verlag Hans Huber; 2000;
  12. Hashimoto M, Yasuda M, Tanimukai S, Matsui M, Girono N, Kazui H, et al. Apolipoprotein E ipsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease. Neurology. 2001;57:1461–1466
  13. Hindmarch I, Lehfeld H, Jongh P, Erzigkeit H. The Bayer Activities of Daily Living Scale (B-ADL). Dementia and Geriatric Cognitive Disorders. 1998;9(Suppl. 2):20–26
  14. Hixon JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. Journal of Lipid Research. 1990;31:545–548
  15. Horínek D, Petrovicky P, Hort J, Krásensky J, Brabec J, Bojar M, et al. Amygdalar volume and psychiatric symptoms in Alzheimer's disease: an MRI analysis. Acta Neurologica Scandinavica. 2006;113:40–45
  16. Horínek D, Varjassyova A, Hort J. Magnetic resonance analysis of amygdalar volume in Alzheimer's disease. Current Opinion in Psychiatry. 2007;20:273–277
  17. Ihl R, Frölich L. Die Reisberg-Skalen. Weinheim: Beltz Verlag; 1991;
  18. Ihl R, Grass-Kapanke B. Manual – Test zur Früherkennung von Demenzen mit Depressionsabgrenzung. Hamburg: Libri Books on Demand; 2000;
  19. Ishiwata A, Sakayori O, Minoshima S, Mizumura S, Kitamura S, Katayama Y. Preclinical evidence of Alzheimer changes in progressive mild cognitive impairment: a qualitative and quantitative SPECT study. Acta Neurologica Scandinavica. 2006;114:91–96
  20. Johnson KA, Jones K, Holman BL, Becker JA, Spiers PA, Satlin A, et al. Preclinical prediction of Alzheimer's disease using SPECT. Neurology. 1998;50:1563–1571
  21. Johnson NA, Jahng G-H, Weiner MW, Miller BL, Chui HC, Jagust WJ, et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: Initial experience. Radiology. 2005;234:851–859
  22. Jorm A. A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychological Medicine. 1994;24:145–153
  23. Kaufmann L, Ischebeck A, Weiss E, Koppelstaetter F, Siedentopf C, Volgel SE, et al. An fMRI study of the numerical Stroop task in individuals with and without minimal cognitive impairment. Cortex. 2008;44:1248–1255
  24. Kertesz A, Nadkarni N, Davidson W, Thomas AW. The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia. Journal of the International. Neuropsychological Society. 2000;6:460–468
  25. Kornhuber J, Schmidtke K, Frölich L, Kurz A, Wolf S, Hampel H, et al. Early and differential diagnosis of dementia and MCI: design and cohort baseline characteristics of the German Competence Net Dementias. Dementia, Geriatric and Cognitive Disorders. 2009;27:404–417
  26. Leenders KL, Perani D, Lammertsma AA, Heather JD, Buckingham P, Healy MJ, et al. Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain. 1990;113:27–47
  27. Lehtovirta M, Laako MP, Soininen H, Helisalmi S, Mannermaa A, Helkala E-L, et al. Volumes of hippocampus, amygdale and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience. 1995;67:65–72
  28. Lehtovirta M, Kuikka J, Helisalmi S, Hartikainen P, Mannermaa A, Ryynänen M, et al. Longitudinal SPECT study in Alzheimer's disease: relation to apolipoprotein E polymorphism. Journal of Neurology, Neurosurgery and Psychiatry. 1998;64:742–746
  29. Luckhaus C, Flüβ MO, Wittsack H-J, Grass-Kapanke B, Jänner M, Khalili-Amiri R, et al. Detection of changed regional cerebral blood flow in mild cognitive impairment and early Alzheimer's dementia by perfusion-weighted magnetic resonance imaging. Neuroimage. 2008;40:495–503
  30. Marien P, Engelborghs S, Fabbro F, De Deyn PP. The lateralized linguistic cerebellum: a review and a new hypothesis. Brain and Language. 2001;79:580–600
  31. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34:939–944
  32. Modrego PJ. Predictors of conversion to dementia of probable Alzheimer type in patients with mild cognitive impairment. Current Alzheimer Research. 2006;3:161–170
  33. Morris JC. The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology. 1997;43:2412–2414
  34. Moscovitch M, Rosenbaum RS, Gilboa A, Addis DR, Westmacott R, Grady C, et al. Functional neuroanatomy of remote episodic, semantic and spatial memory: a unified account based on multiple trace theory. Journal of Anatomy. 2005;207:35–66
  35. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magnetic Resonance in Medicine. 1996;36:715–725
  36. Ostergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results. Magnetic Resonance in Medicine. 1996;36:726–736
  37. Pantano P, Baron JC, Samson Y, Bousser MG, Derouesne C, Comar D. Crossed cerebellar diaschisis. Brain. 1986;109:677–694
  38. Pennanen C, Testa C, Boccardi M, Laasko MP, Hallikainen M, Helkala E-L, et al. The effect of apolipoprotein polymorphism on brain in mild cognitive impairment: a voxel-based morphometric study. Dementia and Geriatric Cognitive Disorders. 2006;22:60–66
  39. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment. Clinical characterization and outcome. Archives of Neurology. 1999;56:303–308
  40. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Archives of Neurology. 2001;58:1985–1992
  41. Pruessner JC, Li LM, Serles W, Pruessner M, Collins DL, Kabani N, et al. Volumetry of hippocampus and amydala with high-resolution MRI and three-dimensional analysis software: minimizing the discrepancies between laboratories. Cerebral Cortex. 2000;10:433–442
  42. Reitan RM. Trail Making Test (TMT). Bern, Göttingen: Hogrefe Verlag; 1979;
  43. Sakamoto S, Matsuda H, Asada T, Ohnishi T, Nakano S, Kanetaka H, et al. Apolipoprotein E genotype and early Alzheimer's disease: a longitudinal SPECT study. Journal of Neuroimaging. 2003;13:113–123
  44. Saunders AM, Trowers MK, Shimkets RA, Blakemore S, Crowther DJ, Mansfield TA, et al. The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection. Biochimica et Biophysica Acta. 2000;1502:85–94
  45. Shulman KI. Clock-drawing: is it the ideal cognitive screening test?. International Journal of Geriatric Psychiatry. 2000;15:548–561
  46. Teipel SJ, Born C, Ewers M, Bokde ALW, Reiser MF, Möller H-J, et al. Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment. Neuroimage. 2007;38:13–24
  47. Thalmann B, Monsch AU, Bernasconi F, Berres M, Schneitter M, Ermini-Fuenfschilling D, et al. Die CERAD Neuropsychologische Testbatterie - Ein gemeinsames minimales Instrumentarium zur Demenzabklärung. In: Memory Clinic, Geriatrische Universitätsklinik Basel. 1998;
  48. Trollor JN, Sachdev PS, Haindl W, Brodaty H, Wen W, Walker BM. A high-resolution single photon emission computed tomography study of verbal recognition memory in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 2006;21:267–274
  49. van de Pol LA, Korf ES, van der Flier WM, Brashear HR, Fox NC, Barkhof F, et al. Magnetic resonance imaging predictors of cognition in mild cognitive impairment. Archives of Neurology. 2007;64:1023–1028
  50. Villain N, Desgranges B, Viader F, de la Sayette V, Mézenge F, Landeau B, et al. Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease. Journal of Neuroscience. 2008;28:6174–6181
  51. Wang L, Zang Y, He Y, Liang M, Zhang X, Tian L, et al. Changes in hippocampal connectivity in the early stages of Alzheimer's disease: evidence from resting state fMRI. Neuroimage. 2006;31:496–504

PII: S0925-4927(10)00116-2

doi: 10.1016/j.pscychresns.2010.04.003

Psychiatry Research: Neuroimaging
Volume 183, Issue 1 , Pages 44-51 , 30 July 2010

Article Tools